This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Data are available from the authors upon reasonable request and with permission of the EBMT.
Leonard A, Bertaina A, Bonfim C, Cohen S, Prockop S, Purtill D, et al. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2021. https://doi.org/10.1016/j.jcyt.2021.09.003.
Iqbal M, Reljic T, Corbacioglu S, de la Fuente J, Gluckman E, Kumar A, et al. Systematic review/meta-analysis on efficacy of allogeneic hematopoietic cell transplantation in sickle cell disease: an international effort on behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium. Transpl Cell Ther. 2021;27:167.e1–12. https://doi.org/10.1016/j.jtct.2020.10.007.
Oikonomopoulou C, Goussetis E. HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe. Bone Marrow Transplant. 2021;56:2882–8. https://doi.org/10.1038/s41409-021-01461-0.
Krishnamurti L. Hematopoietic cell transplantation for sickle cell disease: updates and future directions. Hematol Am Soc Hematol Educ Program. 2021;2021:181–9. https://doi.org/10.1182/hematology.2021000251.
Veloski J, Tai S, Evans AS, Nash DB. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual. 2005;20:151–7. https://doi.org/10.1177/1062860605274520.
Mekelenkamp H, van Zanten H, de Vries M, Lankester A, Smiers F. How to facilitate decision-making for hematopoietic stem cell transplantation in patients with hemoglobinopathies. The perspectives of healthcare professionals. Front Pediatr. 2021;9:690309. https://doi.org/10.3389/fped.2021.690309.
We thank all respondents who participated in the survey.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mekelenkamp, H., de Vries, M., Markovitch, B. et al. Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians’ perspectives. Bone Marrow Transplant (2023). https://doi.org/10.1038/s41409-023-01926-4